These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15943557)

  • 21. Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population.
    Poppelaars FA; Henneman L; Adèr HJ; Cornel MC; Hermens RP; van der Wal G; ten Kate LP
    Genet Test; 2004; 8(2):80-9. PubMed ID: 15345102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cystic fibrosis gene: medical and social implications for heterozygote detection.
    Wilfond BS; Fost N
    JAMA; 1990 May 23-30; 263(20):2777-83. PubMed ID: 2332921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data.
    van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE;
    J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study.
    Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D
    J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population-based genetic screening for cystic fibrosis: attitudes and outcomes.
    Ioannou L; Massie J; Collins V; McClaren B; Delatycki MB
    Public Health Genomics; 2010; 13(7-8):449-56. PubMed ID: 20090299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The views of general practitioners on community carrier screening for cystic fibrosis.
    Boulton M; Cummings C; Williamson R
    Br J Gen Pract; 1996 May; 46(406):299-301. PubMed ID: 8762747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; Ołtarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations.
    Wilfond BS; Fost N
    Milbank Q; 1992; 70(4):629-59. PubMed ID: 1435628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cystic fibrosis carrier screening.
    Massie J; Delatycki MB
    Paediatr Respir Rev; 2013 Dec; 14(4):270-5. PubMed ID: 23466339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal screening for cystic fibrosis carriers: an economic evaluation.
    Rowley PT; Loader S; Kaplan RM
    Am J Hum Genet; 1998 Oct; 63(4):1160-74. PubMed ID: 9758600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis.
    Achterbergh R; Lakeman P; Stemerding D; Moors EH; Cornel MC
    Health Policy; 2007 Oct; 83(2-3):277-86. PubMed ID: 17368860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How should preconceptional cystic fibrosis carrier screening be provided? Opinions of potential providers and the target population.
    Poppelaars FA; Henneman L; Adèr HJ; Cornel MC; Hermens RP; van der Wal G; ten Kate LP
    Community Genet; 2003; 6(3):157-65. PubMed ID: 15237200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening.
    Cunningham F; Lewis S; Curnow L; Glazner J; Massie J
    J Cyst Fibros; 2014 Jan; 13(1):99-105. PubMed ID: 23891279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic screening for cystic fibrosis: an overview of the science and the economics.
    Brice P; Jarrett J; Mugford M
    J Cyst Fibros; 2007 Jul; 6(4):255-61. PubMed ID: 17369107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    Br J Gen Pract; 1996 Apr; 46(405):225-7. PubMed ID: 8703524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers.
    Rowley PT; Loader S; Levenkron JC; Phelps CE
    Am J Prev Med; 1993; 9(5):261-6. PubMed ID: 8257614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.